Miami, Florida — According to state and local economic development sources OrganaBio plans to build out 19,000 square feet of new space in Miami. The company plans to occupy the new space in Miami, on or about August 1, 2021. According to the company website OrganaBio’s proprietary supply chain provides its customers with mission-critical resources, from birth tissue-derived progenitor and immune cells to a suite of expert services and flexible cGMP manufacturing solutions. This enhances our customers’ success in clinical translation and commercialization. We offer our clients a broad array of expertise across a range of disciplines, including: Biomedical Engineering, Cell Biology, Tissue Engineering, Regenerative Medicine, Cell and Gene Therapy, Drug Development, Immunology and Analytical Chemistry.

To learn more about OrganaBio, visit http://www.organabio.com/

Company Contact:
Justin Irizarry, Chief Executive Officer
justin@organabio.com
305-676-2586

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved